Functional assessment of cancer therapy questionnaire for breast cancer (FACTB+ 4). Spanish version validation;Validación de la versión española

Medicina Clinica

Volumn 137, Issue 15, 2011, Pages 685-688

  Martínez, Roser Belmonte ^a,b   Boronat, Olatz Garin ^c,d   Badía, Marcel Segura ^a   Latiesas, Javier Sanz ^a   Navarro, Ester Marco ^a   Fores, Montserrat Ferrer ^b,c,d  

^a Hospital Mar Esperana   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Breast cancer; Lymphedema; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER PATIENT; FEMALE; FUNCTIONAL ASSESSMENT OF CANCER THERAPY QUESTIONNAIRE FOR BREAST CANCER; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SHORT FORM 36; SPAIN; VALIDATION PROCESS; WELLBEING;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84856001537     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.11.028     Document Type: Article

References (10)

1. S. Coster, K. Poole, and L.J. Fallowfield The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively Breast Cancer Res Treat. 68 2001 273 282 (Pubitemid 33702322)
2. D. Castellano, X.G. del Muro, J.L. Pérez-Gracia, J.L. González-Larriba, M.V. Abrio, and M.A. Ruiz Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-{alpha} as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population Ann Oncol. 20 2009 1803 1812
3. Functional Assessment of Chronic Illness Therapy. Disponible en: http//www.facit.org.
4. J. Alonso, E. Regidor, G. Barrio, L. Prieto, C. Rodríguez, and L. de la Fuente Valores poblacionales de referencia de la versión española del cuestionario de salud SF-36 Med Clin (Barc). 111 1998 410 416 (Pubitemid 128524827)
5. G. Vilagut, J. Valderas, M. Ferrer, O. Garin, E. López- García, and J. Alonso Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental Med Clin (Barc). 130 2008 726 735 (Pubitemid 351839702)
6. D.T. Eton, D. Cella, K.J. Yost, S.E. Yount, A.H. Peterman, and D.S. Neuberg A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale J Clin Epidemiol. 57 2004 898 910 (Pubitemid 39422527)
7. A.E. Bonomi, D.F. Cella, E.A. Hahn, K. Bjordal, B. Sperner-Unterweger, and L. Gangeri Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system Qual Life Res. 5 1996 309 320 (Pubitemid 26228464)
8. L. Prieto, R. Lamarca, and A. Casado La evaluación de la fiabilidad en las observaciones clínicas: el coeficiente de correlación intraclase Med Clin (Barc). 110 1998 142 145 (Pubitemid 128530873)
9. M.J. Brady, D.F. Cella, F. Mo, A.E. Bonomi, D.S. Tulsky, and S.R. Lloyd Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument J Clin Oncol. 15 1997 974 986 (Pubitemid 27106280)
10. M. Sprangers, M. Groenvold, J. Arraras, J. Franklin, A. te Velde, and M. Muller The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study J Clin Oncol. 14 1996 2756 2768 (Pubitemid 26329662)